Labomar

Earnings Release • Apr 20, 2023

Press Release Labomar: Q1 2023 consolidated revenues of approx. Euro 28 million, up 47%

Chief Executive Officer Walter Bertin: "We have dealt with the supply chain challenges by maximising the synergies among the Group companies"

Istrana (TV), April 20, 2023 - Labomar SpA (Ticker: LBM), an Italian-based international nutraceutical enterprise and listed on the Euronext Growth Milan market, announces Q1 2023 consolidated revenues of approx. Euro 28 million, up 47% on the same period of 2022 (Euro 19 million).

53% of revenues were from overseas, supported by all the Group's companies, who have successfully tapped into market opportunities, although within a still challenging environment.

In Q1 2023, the parent company Labomar S.p.A.'s sales amounted to approx. Euro 20.6 million, up 45.2% over the same period of 2022. This result reflects the significant recovery of the cough&cold and probiotics market, which had emerged by the second half of last year. The revenues of Entreprises ImportFab Inc. and the Welcare Group also grew significantly, while Labiotre S.r.l.'s revenues remained stable.

"I am extremely pleased with these quarterly results, which indicate an expansion which had already emerged from the second half of last year " outlined Chief Executive Officer and founder Walter Bertin. "Even against a socio-economic backdrop that continues to present complexities, the Labomar Group has been able to effectively deal with the supply chainrelated challenges, maximising synergies within the scope of companies for both international business development and the proposal of new products. We look to the second half of the year with caution, in view of the heavy impact of inflation and its effects on consumer spending capacity. We therefore expect a consolidation phase of the results achieved to date."

The company also announces that the Shareholders' Meeting, whose call notice was published last April 12 on the website, on the company website (www.labomar.com) in the "Governance/Shareholders' Meeting" section, and in extract form in the IlSole24Ore newspaper, shall be held in second call on May 4 at 9AM.

Labomar Profile

Founded by Walter Bertin in Istrana (province of Treviso) in 1998, Labomar is specialised in the development and production of food supplements, medical devices, foods for special medical purposes and cosmetics for third parties. Over more than 20 years, Labomar has built a business model which sets it apart from its competitors and generates value for all stakeholders, providing a comprehensive service and a high quality and productivity standard. The company boasts a well-structured and cutting-edge research and development department with a particular focus on innovation, a commercial team which reacts quickly to market demands and a high level of product differentiation thanks to its proprietary patents and formulas.

Following the acquisitions of the Welcare Group and Labiotre Srl, in addition to the establishment of LaboVar Srl, in 2022 Labomar focused on maximising the synergies among the various companies, pooling resources and expertise to expand its product portfolio, enter new markets and streamline certain processes, including through the best practices brought by each of the Group companies.

Labomar whole-heartedly believes in a business system based on sustainability and a real concern for people, the environment and the community. It therefore by 2020 had gained Benefit Company status and simultaneously embarked on obtaining B-Corp Certification, for which it has already applied to the relative body for certification issuance. This is testament to the company's decision to pursue a model of responsible, sustainable and transparent development, which integrates operating and earnings objectives with social and environmental aspects.

For further information: Labomar Press Office Thanai Bernardini - +39.335.7245418 - me@thanai.it Alessandro Bozzi Valenti - +39.348.0090866 - alessandro.valenti@thanai.it Margherita Bertolo - +39.328.5574976 - margherita.bertolo@thanai.it

Investor Relations Labomar Claudio De Nadai - +39.0422.677203 - claudio.denadai@labomar.com Mara Di Giorgio - +39 335 7737417 - mara@twin.services

Euronext Growth Advisor Banca Mediolanum - +39 02 9049 2525 - ecm@mediolanum.it